CytoMed Therapeutics Pte Ltd
2 clinical trials · Sponsor
◉ Watch CytoMed Therapeutics Pte Ltd
| Record | Firm | Date |
|---|---|---|
| Allogeneic NKG2DL-targeting CAR γδ T Cells (CTM-N2D) in Advanced Cancers (ANGELICA) (NCT05302037) | CytoMed Therapeutics Pte Ltd | 2024-11-19 |
| Haplo / Allogeneic NKG2DL-targeting Chimeric Antigen Receptor-grafted γδ T Cells for Relapsed or Refractory Solid Tumour (NCT04107142) | CytoMed Therapeutics Pte Ltd | 2019-12-01 |
Track CytoMed Therapeutics Pte Ltd automatically
Every clearance here is in the API, with alerts when new ones post.